Join the club for FREE to access the whole archive and other member benefits.

Senolytic Therapeutics (Senolytx)

Pharmaceutical company that develops a novel class of medicines by targeting damaged cells.

Senolytic Therapeutics is a operator of a pharmaceutical company intended to develop medicines and therapeutics for patients affected by age-related diseases. The company's medicines target and eliminate damaged cells, enabling healthcare providers to improve the lives of those affected by diseases associated with aging.

Visit website:


Details last updated 04-May-2019

People at Senolytic Therapeutics (Senolytx)

Timothy (Tim) Cash

Chief Scientific Officer at Senolytic Therapeutics.

Senolytic Therapeutics (Senolytx) News

LMC provides background and success outlook on 14 leading senolytic companies

Longevity Marketcap - 15-Dec-2020

Comprehensive review of companies' clinical and financial state of play


Nature Biotechnology reviews the state of play of senolytics

Nature Biotechnology - 12-Nov-2020

In August, Unity announced that its lead drug candidate had failed to beat a placebo in reducing ...


Labiotech gathers feedback from European biotechs on Unity failure

Labiotech - 28-Aug-2020

General feeling that failures are bound to happen - but that their approaches can succeed


LEAF report from the Longevity Leaders Conference (LEAF) - 06-Feb-2019

Encouraging signs from big companies - more interviews to follow

Topics mentioned on this page:
Senescent Cells, Laboratory Automation